Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/54019
Title: Prevalence and drug treatment of the parkinsonian syndrome in Malta
Authors: Serracino-Inglott, Anthony
Farrugia, Simone
Ferrito, Mary Nancy
Keywords: Symptomatic Parkinson's disease
Dopa -- Physiological effect
Parasympatholytic agents
Acetylcholine -- Receptors
Issue Date: 1992
Publisher: Elsevier B.V.
Citation: Serracino-Inglott, A., Farrugia, S., & Ferrito, M. N. (1992). Prevalence and drug treatment of the Parkinsonian syndrome in Malta. Dementia and Geriatric Cognitive Disorders, 3(1), 47-57.
Abstract: The prevalence of the parkinsonian syndrome in Malta was determined from a retrospective study conducted on 34 patients who were suffering from the parkinsonian syndrome at a geriatric residence. A crude prevalence rate of 92.8 per 100,000 population was obtained. Idiopathic Parkinson's disease was the most common variant. A study of drug treatment showed that a longer improvement period is obtained by initiating de novo parkinsonian patients on anticholinergic drug treatment and then transferring them to L-dopa-carbidopa when disease progression renders anticholinergic drug treatment in efficacious
URI: https://www.um.edu.mt/library/oar/handle/123456789/54019
Appears in Collections:Scholarly Works - FacM&SPha

Files in This Item:
File Description SizeFormat 
Prevalence_and_drug_treatment_of_the_parkinsonian_syndrome_in_Malta.pdf
  Restricted Access
1.41 MBAdobe PDFView/Open Request a copy


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.